Here, we demonstrate that AKT inhibition reduces NOTCH1 signaling and cell viability through activation of GSK3β in CLL cells lacking NOTCH1 mutations, suggesting that GSK3β inactivation induced by AKT plays a role in promoting NOTCH1-associated survival. This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.